Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP340323.RABnbJYtIF5Rgq-NGiRl-Zku2d0uzkfC1m6MDqAzapHNw130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP340323.RABnbJYtIF5Rgq-NGiRl-Zku2d0uzkfC1m6MDqAzapHNw130_assertion type Assertion NP340323.RABnbJYtIF5Rgq-NGiRl-Zku2d0uzkfC1m6MDqAzapHNw130_head.
- NP340323.RABnbJYtIF5Rgq-NGiRl-Zku2d0uzkfC1m6MDqAzapHNw130_assertion description "[To test targeted candidate gene variation for association with subclinical CVD defined by carotid artery intima-media thickness (CIMT) and coronary artery calcification (CAC), 610 women participating in the Kronos Early Estrogen Prevention Study (KEEPS), a clinical trial of MHT to prevent progression of CVD, were genotyped for 13,229 single nucleotide polymorphisms (SNPs) within 764 genes from anticoagulant, procoagulant, fibrinolytic, or innate immunity pathways.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP340323.RABnbJYtIF5Rgq-NGiRl-Zku2d0uzkfC1m6MDqAzapHNw130_provenance.
- NP340323.RABnbJYtIF5Rgq-NGiRl-Zku2d0uzkfC1m6MDqAzapHNw130_assertion evidence source_evidence_literature NP340323.RABnbJYtIF5Rgq-NGiRl-Zku2d0uzkfC1m6MDqAzapHNw130_provenance.
- NP340323.RABnbJYtIF5Rgq-NGiRl-Zku2d0uzkfC1m6MDqAzapHNw130_assertion SIO_000772 23188791 NP340323.RABnbJYtIF5Rgq-NGiRl-Zku2d0uzkfC1m6MDqAzapHNw130_provenance.
- NP340323.RABnbJYtIF5Rgq-NGiRl-Zku2d0uzkfC1m6MDqAzapHNw130_assertion wasDerivedFrom befree-20140225 NP340323.RABnbJYtIF5Rgq-NGiRl-Zku2d0uzkfC1m6MDqAzapHNw130_provenance.
- NP340323.RABnbJYtIF5Rgq-NGiRl-Zku2d0uzkfC1m6MDqAzapHNw130_assertion wasGeneratedBy ECO_0000203 NP340323.RABnbJYtIF5Rgq-NGiRl-Zku2d0uzkfC1m6MDqAzapHNw130_provenance.